IDiyas

For the Inventor, By the Inventor

New York, NY, United States of America

Kambiz Shekdar

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:

goldMedal9 out of 13 
 
Chromocell Corporation
 patents
silverMedal3 out of 267 
 
Kraft Foods Group Brands LLC
 patents
bronzeMedal1 out of 1 
 
Research Foundation To Cure Aids, Inc.
 patent
4. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2004-2023

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 11680265 - Genome editing using effector oligonucleotides for therapeutic treatment (2023-06-20),
2. 10669547 - Genome editing using effector oligonucleotides for therapeutic treatment (2020-06-02),
3. 9872514 - Compounds, compositions, and methods for reducing or eliminating bitter taste (2018-01-23),
4. 9657357 - Methods and compositions for identifying and validating modulators of cell fate (2017-05-23),
5. 9534035 - Cell lines expressing ENaC and methods using them (2017-01-03),
6. 9408407 - Compounds, compositions, and methods for reducing or eliminating bitter taste (2016-08-09),
7. 9347934 - Assays for identifying compounds that modulate bitter taste (2016-05-24),
8. 8945848 - Methods and compositions for identifying and validating modulators of cell fate (2015-02-03),
9. 8916503 - Methods and materials using signaling probes (2014-12-23),
10. 8865779 - Compounds, compositions, and methods for reducing or eliminating bitter taste (2014-10-21),
11. 6692965 - Isolation of living cells and preparation of cell lines based on detection and quantification of preselected cellular ribonucleic acid sequences (2004-02-17),

Title: Innovator Spotlight: Kambiz Shekdar Revolutionizing Genome Editing for Therapeutic Treatment

Introduction

Kambiz Shekdar, a renowned inventor based in New York, NY, is making waves in the world of genome editing with his groundbreaking inventions. With a total of 11 patents to his name, Shekdar's work is paving the way for more effective and precise therapeutic treatments using effector oligonucleotides.

Latest Patents

His latest patents focus on "Genome editing using effector oligonucleotides for therapeutic treatment." These innovative compositions and methods involve effector oligonucleotides with greater than one mismatch compared to the target sequence. These advancements not only improve the efficiency of genomic editing but also offer potential therapeutic benefits for individuals in need.

Career Highlights

Throughout his career, Shekdar has made significant contributions to the field of biotechnology. He has worked with prestigious companies such as Chromocell Corporation and Kraft Foods Group Brands LLC, where his expertise and innovative spirit have been instrumental in driving forward exciting developments in the industry.

Collaborations

In his collaborative efforts, Shekdar has worked closely with esteemed colleagues such as Jessica Langer and Joseph Gunnet. Together, they have synergized their skills and expertise to push the boundaries of genome editing and bring about impactful changes in the realm of therapeutic treatments.

Conclusion

In conclusion, Kambiz Shekdar's dedication to innovation and advancement in genome editing is evident through his prolific patent portfolio and successful career milestones. His contributions are reshaping the landscape of biotechnology and holding promising prospects for future therapeutic interventions. Shekdar continues to inspire with his inventive spirit and unwavering commitment to driving positive change in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…